Alpine Immune Sciences Inc (ALPN)
64.59
-0.01
(-0.02%)
USD |
NASDAQ |
May 02, 16:00
64.60
+0.02
(+0.02%)
After-Hours: 20:00
Alpine Immune Sciences Profit Margin (Quarterly): 19.32% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 19.32% |
| September 30, 2023 | -116.7% |
| June 30, 2023 | -153.1% |
| March 31, 2023 | -141.3% |
| December 31, 2022 | -679.5% |
| September 30, 2022 | -158.6% |
| June 30, 2022 | -342.0% |
| March 31, 2022 | -55.23% |
| December 31, 2021 | -334.8% |
| September 30, 2021 | -158.5% |
| June 30, 2021 | -153.3% |
| March 31, 2021 | -332.2% |
| December 31, 2020 | -112.4% |
| Date | Value |
|---|---|
| September 30, 2020 | -320.8% |
| June 30, 2020 | -1.44K% |
| March 31, 2020 | -507.1% |
| December 31, 2019 | -694.6% |
| September 30, 2019 | -3.97K% |
| June 30, 2019 | -2.09K% |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | -2.03K% |
| March 31, 2018 | -1.68K% |
| December 31, 2017 | -3.37K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-3.97K%
Minimum
Sep 2019
19.32%
Maximum
Dec 2023
-618.2%
Average
-320.8%
Median
Sep 2020
Profit Margin (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 38.48% |
| Eliem Therapeutics Inc | -- |
| Regeneron Pharmaceuticals Inc | 33.77% |
| Vera Therapeutics Inc | -- |
| Eyenovia Inc | -307.7K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -15.97% |
| Return on Assets | -11.32% |
| Return on Invested Capital | -15.88% |
| Operating Margin (Quarterly) | 5.01% |
| Return on Net Operating Assets | -228.6% |